T.A. Abdallah, K.M. Dawood / Tetrahedron 64 (2008) 7890–7895
7893
3.4.1. 3-(Phenylhydrazono)-2,3,5,6-tetrahydro-8,9-dimethoxy-2-
oxopyrrolo[2,1-a]-isoquinoline-1-carbonitrile (4a)
1H). Anal. Calcd for C23H21BrN2O4: C, 58.86; H, 4.51; N, 5.97. Found:
C, 58.64; H, 4.59; N, 5.81%.
Brownish red crystals (0.51 g, 68%); mp 294–296 ꢀC; IR (KBr)
n
1727 (C]O), 2197 (C^N) cmꢁ1
;
1H NMR (DMSO-d6)
d
3.03 (t, 2H,
3.5.5. Isoquinolinium salt 7e
J¼6.9 Hz), 3.82 (s, 3H), 3.84 (s, 3H), 3.7 (t, 2H, J¼6.9 Hz), 7.0 (s, 1H),
7.4 (s, 1H), 7.6–7.7 (m, 5H), 12.5 (s, 1H, NH); MS (m/z) (%), 374 (Mþ,
100), 269 (2.3), 241 (48.5), 227 (25.2), 211 (45.8), 197 (9.3), 167 (8.6),
128 (8.3), 77 (9.7), 51 (12.5). Anal. Calcd for C21H18N4O3: C, 67.37; H,
4.85; N, 14.96. Found: C, 67.60; H, 4.63; N, 14.77%.
Yellowish-white crystals (0.75 g, 76%); mp>300 ꢀC (dioxane); IR
(KBr)
n ; d 3.05 (t,
1715 (C]O), 2212 (C^N) cmꢁ1 1H NMR (CDCl3)
2H, J¼6.3 Hz), 3.93 (s, 3H), 3.98 (s, 3H), 4.05 (t, 2H, J¼6.3 Hz), 4.76 (s,
4H), 6.64 (s, 1H), 6.76 (s, 1H), 7.38–7.43 (m, 2H), 7.69–7.82 (m, 2H),
8.64 (s, 1H). Anal. Calcd for C24H21BrN2O5: C, 57.96; H, 4.26; N, 5.63.
Found: C, 57.80; H, 4.34; N, 5.42%.
3.4.2. 3-(p-Tolylhydrazono)-2,3,5,6-tetrahydro-8,9-dimethoxy-2-
oxopyrrolo[2,1-a]-isoquinoline-1-carbonitrile (4b)
3.6. Synthesis of 2-arylpyrrolo[2,1-a]isoquinoline-1-
carbonitriles 9a–e
Intense red powder (0.58 g, 75%); mp 261–263 ꢀC; IR (KBr)
n
1724 (C]O), 2203 (C^N) cmꢁ1; 1H NMR (DMSO-d6)
d 2.26 (s, 3H),
3.03 (t, 2H, J¼6.3 Hz), 3.78 (t, 2H, J¼6.3 Hz), 3.80 (s, 3H), 3.81 (s, 3H),
7.0 (s, 1H), 7.15 (d, 2H, J¼8.4 Hz), 7.29 (d, 2H, J¼8.4 Hz), 7.6 (s, 1H),
12.51 (s, 1H, NH); MS (m/z) (%), 388 (Mþ, 100), 373 (3.5), 268 (2.4),
255 (6), 223 (2.9), 194 (5), 106 (9.3). Anal. Calcd for C22H20N4O3: C,
68.03; H, 5.19; N, 14.42. Found: C, 68.28; H, 5.47; N, 14.25%.
To a solution of the appropriate isoquinolinium bromides 7a–e
(2 mmol) in dry benzene (30 mL), triethylamine (0.4 mL) was
added and the reaction mixture was refluxed 2–4 h, then left to cool
to room temperature. The triethylamine–hydrobromide salt was
removed by filtration and the filtrate was evaporated under vac-
uum. The residue was triturated with methanol and the solid
formed was filtered off, washed with methanol and dried. Re-
crystallization from proper solvent afforded the corresponding
pyrrolo[2,1-a]isoquinoline-1-carbonitrile derivatives 9a–e.
3.4.3. 3-(p-Chlorophenylhydrazono)-2,3,5,6-tetrahydro-8,9-
dimethoxy-2-oxopyrrolo[2,1-a]-isoquinoline-1-carbonitrile (4c)
Orange red powder (0.57 g, 70%); mp 278–280 ꢀC; IR (KBr)
n
1679 (C]O), 2204 (C^N) cmꢁ1; MS (m/z) (%), 408 (Mþ, 100), 225
(9.2), 127 (15.1), 101 (6), 90 (16.1), 63 (10.2). Anal. Calcd for
3.6.1. 5,6-Dihydro-8,9-dimethoxy-2-phenylpyrrolo[2,1-a]-
isoquinoline-1-carbonitrile (9a)
C
21H17ClN4O3: C, 61.69; H, 4.19; N, 13.70. Found: C, 61.78; H, 4.33;
N, 13.49%.
Yellow crystals (0.45 g, 69%); mp 208–210 ꢀC (ethanol); IR (KBr)
n
2212 (C^N) cmꢁ1; 1H NMR (CDCl3)
d
3.0 (t, 2H, J¼6.6 Hz), 3.91 (s,
3H), 3.96 (s, 3H), 4.09 (t, 2H, J¼6.6 Hz), 6.48 (s, 1H), 6.75 (s, 1H),
7.34–7.44 (m, 5H), 7.75 (s, 1H); 13C NMR
28.8, 42.3, 55.9, 56.1, 86.9,
3.5. Synthesis of the isoquinolinium salts 7a–e
d
To a solution of the appropriate
a
-bromoketone derivatives
107.0, 110.9, 111.7, 118.3, 119.9, 124.7, 128.1, 128.7, 128.8, 130.8, 134.1,
136.3, 148.4, 148.9; MS (m/z) (%), 330 (Mþ, 100), 243 (17.6), 230
(27.8), 165 (12.1), 86 (8.5). Anal. Calcd for C21H18N2O2: C, 76.36; H,
5.46; N, 8.48. Found: C, 76.15; H, 5.32; N, 8.71%.
6a–e (2 mmol) in dry benzene (20 mL), isoquinoline-1-acetonitrile
1 (0.46 g, 2 mmol) was added. The mixturewas refluxed for 2 h, then
left to cool. The solid product was filtered off, washed with ether
and dried to afford the isoquinolinium bromides 7a–e, respectively.
3.6.2. 2-(4-Bromophenyl)-5,6-dihydro-8,9-dimethoxypyrrolo-
[2,1-a]isoquinoline-1-carbonitrile (9b)
3.5.1. Isoquinolinium salt 7a
Yellowish-brown crystals (0.59 g, 69%); mp 184–186 ꢀC (meth-
Yellowish-brown powder (0.59 g, 73%); mp 174–176 ꢀC (meth-
anol); IR (KBr)
d6)
n
1644 (C]O), 2253 (C^N) cmꢁ1
;
1H NMR (DMSO-
anol); IR (KBr) n ; d 2.87 (t, 2H,
2177 (C^N) cmꢁ1 1H NMR (CDCl3)
d
2.50 (s, 2H), 2.75 (t, 2H, J¼6.3 Hz), 3.24 (t, 2H, J¼6.3 Hz), 3.77
J¼6.3 Hz), 3.43 (t, 2H, J¼6.3 Hz), 3.90 (s, 3H), 3.92 (s, 3H), 5.57 (s,
1H), 6.67 (s, 1H), 6.99 (s, 1H), 7.61 (d, 2H, J¼6.9 Hz), 7.78 (d, 2H,
J¼6.9 Hz); MS (m/z) (%), 409 (Mþ, 13.6), 230 (6.8), 101 (19.9), 86
(100), 79 (12.7), 58 (37.2). Anal. Calcd for C21H17BrN2O2: C, 61.63; H,
4.16; N, 6.84. Found: C, 61.38; H, 3.92; N, 6.95%.
(s, 3H), 3.79 (s, 2H), 3.82 (s, 3H), 6.98 (s, 1H), 7.16–7.49 (m, 5H), 7.62
(s, 1H). Anal. Calcd for C21H21BrN2O3: C, 58.75; H, 4.93; N, 6.53.
Found: C, 58.94; H, 5.03; N, 6.77%.
3.5.2. Isoquinolinium salt 7b
Brown crystals (0.72 g, 71%); mp 152–154 ꢀC (methanol); IR
(KBr)
(t, 2H, J¼6.3 Hz), 3.44 (t, 2H, J¼6.3 Hz), 3.88 (s, 3H), 3.91 (s, 3H), 4.24
(s, 2H), 4.40 (s, 2H), 6.67 (s, 1H), 6.98 (s, 1H), 7.65 (d, 2H, J¼6.9 Hz),
7.86 (d, 2H, J¼6.9 Hz). Anal. Calcd for C21H20Br2N2O3: C, 49.63; H,
3.97; N, 5.51. Found: C, 49.46; H, 3.68; N, 5.22%.
3.6.3. 2-(Benzothiazol-2-yl)-5,6-dihydro-8,9-dimethoxy-
pyrrolo[2,1-a]isoquinoline-1-carbonitrile (9c)
n d 2.83
1649 (C]O), 2253 (C^N) cmꢁ1; 1H NMR (DMSO-d6)
Pale brown crystals (0.55 g, 72%); mp 264–266 ꢀC (acetic acid);
IR (KBr)
n ; d 3.03 (t, 2H,
2215 (C^N) cmꢁ1 1H NMR (CDCl3)
J¼6.9 Hz), 3.87 (s, 3H), 3.91 (s, 3H), 4.84 (t, 2H, J¼6.9 Hz), 6.72 (s,
1H), 7.01 (s, 1H), 7.30–7.41 (m, 2H), 7.74 (s, 1H), 7.79 (d, 1H,
J¼7.2 Hz), 7.92 (d, 1H, J¼7.2 Hz); MS (m/z) (%), 387 (Mþ, 100), 345
(6.7), 328 (8.1), 300 (7.3), 156 (12), 69 (8.1). Anal. Calcd for
C22H17N3O2S: C, 68.22; H, 4.42; N, 10.85; S, 8.28. Found: C, 68.05; H,
4.37; N, 10.72; S, 8.43%.
3.5.3. Isoquinolinium salt 7c
Brown powder (0.71 g, 74%); mp 233–235 ꢀC (DMF); IR (KBr)
n
1649 (C]O), 2214 (C^N) cmꢁ1
;
1H NMR (CDCl3)
d
3.03 (t, 2H,
J¼6.9 Hz), 3.86 (s, 3H), 3.92 (s, 3H), 3.94 (s, 2H), 4.83 (t, 2H,
J¼6.9 Hz), 4.89 (s, 2H), 6.72 (s, 1H), 7.27–7.40 (m, 2H), 7.77 (s, 1H),
7.79 (d, 1H, J¼7.8 Hz), 7.93 (d, 1H, J¼7.8 Hz). Anal. Calcd for
3.6.4. 2-(2-Benzofuryl)-5,6-dihydro-8,9-dimethoxypyrrolo[2,1-a]-
isoquinoline-1-carbonitrile (9d)
C
22H20BrN3O3S: C, 54.32; H, 4.14; N, 8.62; S, 6.58. Found: C, 54.15; H,
Pale yellow crystals (0.49 g, 67%); mp 218–220 ꢀC (DMF); IR
3.95; N, 8.74; S, 6.46%.
(KBr)
n
2214 (C^N) cmꢁ1; 1H NMR (CDCl3)
d
3.09 (t, 2H, J¼6.9 Hz),
3.95 (s, 3H), 3.99 (s, 3H), 4.42 (t, 2H, J¼6.9 Hz), 6.79 (s, 1H), 6.81 (s,
1H), 6.89 (s, 1H), 7.28–7.35 (m, 2H), 7.79 (d, 1H, J¼8.4 Hz), 7.92 (d,
3.5.4. Isoquinolinium salt 7d
Yellow crystals (0.62 g, 67%); mp 201–203 ꢀC (ethanol); IR (KBr)
1H, J¼8.4 Hz), 7.80 (s, 1H); 13C NMR
d 28.5, 42.7, 56.0, 56.1, 87.7,
n
1651 (C]O), 2217 (C^N) cmꢁ1
;
1H NMR (CDCl3)
d
3.01 (t, 2H,
104.0, 107.2, 110.8, 111.0, 113.6, 117.7, 119.3, 120.8, 123.2, 124.0,
124.5, 124.6, 128.3, 137.4, 147.2, 148.5, 149.4, 154.5; MS (m/z) (%),
370 (Mþ, 100), 355 (23.3), 327 (22.5), 185 (12.8), 89 (2.4). Anal.
J¼6.9 Hz), 3.94 (s, 3H), 3.96 (s, 3H), 3.99 (s, 2H), 4.05 (s, 2H), 4.38 (t,
2H, J¼6.9 Hz), 6.79 (s, 1H), 6.89 (s, 1H), 7.29–7.59 (m, 4H), 7.80 (s,